v3.25.0.1
Summary of the Warrants (Details) - $ / shares
Sep. 30, 2024
Mar. 13, 2024
Dec. 31, 2023
Jul. 31, 2023
May 18, 2023
Apr. 10, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares 10,905,901   7,070,627      
Exercise price   $ 8.10       $ 7.50
Expiration date         May 18, 2028  
Dragasac Warrant [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares 652,981 [1]   652,981 [2]      
Exercise price $ 2.4898 [1]   $ 67.70 [2]      
Expiration date Mar. 16, 2025 [1]   Mar. 16, 2025 [2]      
Public Warrants [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares 1,437,447 [3]   1,437,447 [4]      
Exercise price $ 115.00 [3]   $ 115.00 [4]      
Expiration date Jul. 16, 2026 [3]   Jul. 16, 2026 [4]      
Sponsor Warrants [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares 849,999 [3]   849,999 [4]      
Exercise price $ 115.00 [3]   $ 115.00 [4]      
Expiration date Jul. 16, 2026 [3]   Jul. 16, 2026 [4]      
May Two Thousand Twenty Two Private Investment In Public Equity Warrants [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares 405,405   405,405      
Exercise price $ 3.50   $ 3.50      
Expiration date Oct. 10, 2028   Oct. 10, 2028      
March Two Thousand Twenty Three Private Investment In Public Equity Warrants [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares 208,485   208,485      
Exercise price $ 30.00   $ 30.00      
Expiration date Mar. 27, 2028   Mar. 27, 2028      
March Two Thousand Twenty Three Private Investment in Public Equity Warrants, Modified [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares 729,698   729,698      
Exercise price $ 10.00   $ 10.00      
Expiration date Mar. 27, 2028   Mar. 27, 2028      
March Two Thousand Twenty Three Loan Warrants [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares 75,000 [5]   75,000      
Exercise price $ 5.895 [5]   $ 7.10      
Expiration date Mar. 17, 2028 [5]   Mar. 17, 2028      
April Two Thousand Twenty Three Registered Direct Warrants [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares 435,625   435,625      
Exercise price $ 7.50   $ 7.50      
Expiration date Oct. 10, 2028   Oct. 10, 2028      
April Two Thousand Twenty Three Registered Direct Warrants Modified [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares 487,451   487,451 487,451    
Exercise price $ 3.50   $ 3.50      
Expiration date Oct. 10, 2028   Oct. 10, 2028      
May Two Thousand Twenty Three Private Investment In Public Equity Warrants [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares 581,394   581,394      
Exercise price $ 10.00   $ 10.00   $ 10.00  
Expiration date May 17, 2028   May 17, 2028   May 17, 2028  
June Two Thousand Twenty Three Warrants [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares 50,000 [5]   50,000      
Exercise price $ 5.895 [5]   $ 8.10      
Expiration date Jun. 20, 2028   Jun. 20, 2028      
June Two Thousand Twenty Three Loan Warrants [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares 300,000   300,000      
Exercise price $ 8.10   $ 8.10      
Expiration date Jun. 20, 2028   Jun. 20, 2028      
July Two Thousand Twenty Three Registered Direct Warrants [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares 857,142   857,142      
Exercise price $ 3.50   $ 3.50      
Expiration date Jan. 31, 2029   Jan. 31, 2029      
January Two Thousand Twenty Four Pipe Warrants [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares 535,274          
Exercise price $ 2.4898          
Expiration date Jan. 16, 2029          
January 2024 Bridge Loan Tranche One Warrants [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares 1,650,000          
Exercise price $ 2.4898          
Expiration date Jan. 16, 2029          
January Two Thousand Twenty Four Bridge Loan Tranche Two Warrants [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares 1,350,000          
Exercise price $ 2.988          
Expiration date Jul. 15, 2029          
March 2024 Rwi Forbearance Warrants [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares 300,000          
Exercise price $ 5.895          
Expiration date Jun. 20, 2028          
[1] In connection with the execution of the January 2024 PIPE described above, the Company agreed to reprice 652,981 legacy warrants held by Dragasac with a previous exercise price of $67.70 to a new exercise price of $2.4898. The term of the warrants was unchanged.
[2] The exercise price is the lesser of $67.70 per share or 80% of either (i) the value attributed to one share of Legacy Celularity Series B Preferred Stock upon consummation of a change in control or the closing of a strategic transaction or (ii) the price at which one share of common stock is sold to the public market in an initial public offering.
[3] The number of Public Warrants and Sponsor Warrants outstanding was not adjusted for the reverse stock split. There are 14,374,478 Public Warrants and 8,499,999 Sponsor Warrants outstanding. After the reverse stock split, the number of warrants outstanding remains the same. However, each outstanding warrant is now exercisable for one-tenth of a share of Class A common stock, and the exercise price per share was adjusted to $115.00 as a result of the split.
[4] The number of Public Warrants and Sponsor Warrants outstanding was not adjusted for the reverse stock split. There are 14,374,478 Public Warrants and 8,499,999 Sponsor Warrants outstanding. After the reverse stock split, the number of warrants outstanding remains the same. However, each outstanding warrant is now exercisable for one-tenth of a share of Class A common stock, and the exercise price per share was adjusted to $115.00 as a result of the split.
[5] In connection with the execution of the Starr Forbearance Agreement on March 13, 2024, described above under Warrant Modification and further in Note 7, the Company agreed to reprice 75,000 warrants with a previous exercise price of $7.10 and 50,000 warrants with a previous exercise price of $8.10 held by C.V. Starr to a new exercise price of $5.895. The term of the warrants was unchanged.